Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$11.78
-3.9%
$13.36
$7.94
$19.11
$1.03B1.72869,828 shs925,234 shs
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$17.05
-6.4%
$18.77
$16.43
$30.28
$4.56B1.034.02 million shs2.60 million shs
10x Genomics stock logo
TXG
10x Genomics
$31.04
-7.3%
$23.65
$9.21
$35.65
$4.25B2.122.97 million shs3.80 million shs
Vontier Corporation stock logo
VNT
Vontier
$28.19
-0.5%
$32.92
$27.25
$48.20
$3.99B1.162.29 million shs1.54 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-0.65%-9.19%-10.84%-22.16%+49.51%
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
-0.43%+6.28%-9.65%-11.67%-7.16%
10x Genomics stock logo
TXG
10x Genomics
+4.17%+19.69%+52.20%+60.98%+258.67%
Vontier Corporation stock logo
VNT
Vontier
-0.53%-1.82%-18.89%-26.25%-21.12%
CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$11.78
-3.9%
$13.36
$7.94
$19.11
$1.03B1.72869,828 shs925,234 shs
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$17.05
-6.4%
$18.77
$16.43
$30.28
$4.56B1.034.02 million shs2.60 million shs
10x Genomics stock logo
TXG
10x Genomics
$31.04
-7.3%
$23.65
$9.21
$35.65
$4.25B2.122.97 million shs3.80 million shs
Vontier Corporation stock logo
VNT
Vontier
$28.19
-0.5%
$32.92
$27.25
$48.20
$3.99B1.162.29 million shs1.54 million shs
Options Trading Made Easy - Download Now Cover

Learn the basics of options trading and how to use them to boost returns and manage risk with this free report from MarketBeat. Click the link below to get your free copy.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-0.65%-9.19%-10.84%-22.16%+49.51%
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
-0.43%+6.28%-9.65%-11.67%-7.16%
10x Genomics stock logo
TXG
10x Genomics
+4.17%+19.69%+52.20%+60.98%+258.67%
Vontier Corporation stock logo
VNT
Vontier
-0.53%-1.82%-18.89%-26.25%-21.12%
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
3.00
Buy$31.80169.95% Upside
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
2.80
Moderate Buy$27.1359.05% Upside
10x Genomics stock logo
TXG
10x Genomics
2.20
Hold$23.17-25.37% Downside
Vontier Corporation stock logo
VNT
Vontier
2.40
Hold$42.3850.34% Upside

Current Analyst Ratings Breakdown

Latest EYPT, MIR, VNT, and TXG Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
5/26/2026
Vontier Corporation stock logo
VNT
Vontier
DowngradeBuyHold
5/19/2026
Vontier Corporation stock logo
VNT
Vontier
DowngradeHold (C+)Hold (C)
5/18/2026
10x Genomics stock logo
TXG
10x Genomics
DowngradeStrong-BuyHold
5/12/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetEqual Weight$20.00 ➝ $22.00
5/12/2026
10x Genomics stock logo
TXG
10x Genomics
Boost Price TargetNeutral$17.00 ➝ $20.00
5/11/2026
Vontier Corporation stock logo
VNT
Vontier
Set Price Target$36.00
5/8/2026
Vontier Corporation stock logo
VNT
Vontier
Set Price Target$37.00
5/8/2026
Vontier Corporation stock logo
VNT
Vontier
Lower Price TargetBuy$50.00 ➝ $44.00
5/8/2026
Vontier Corporation stock logo
VNT
Vontier
Lower Price TargetOverweight$50.00 ➝ $45.00
5/8/2026
Vontier Corporation stock logo
VNT
Vontier
Lower Price TargetOverweight$50.00 ➝ $40.00
5/7/2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
Lower Price TargetOutperform$39.00 ➝ $37.00
(Data available from 6/5/2023 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
$31.37M31.48N/AN/A$3.70 per share3.18
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$925.40M4.61$1.01 per share16.83$8.25 per share2.07
10x Genomics stock logo
TXG
10x Genomics
$642.82M6.13N/AN/A$6.24 per share4.97
Vontier Corporation stock logo
VNT
Vontier
$3.08B1.29$4.19 per share6.72$8.84 per share3.19
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$231.96M-$3.50N/AN/AN/A-3,566.63%-110.54%-90.15%8/5/2026 (Estimated)
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$28.80M$0.10170.5427.96N/A2.56%6.44%3.48%7/30/2026 (Estimated)
10x Genomics stock logo
TXG
10x Genomics
-$43.54M-$0.17N/AN/AN/A-3.55%-2.86%-2.23%8/6/2026 (Estimated)
Vontier Corporation stock logo
VNT
Vontier
$406.10M$2.839.967.681.0713.37%37.88%10.90%7/30/2026 (Estimated)

Latest EYPT, MIR, VNT, and TXG Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
5/7/2026Q1 2026
10x Genomics stock logo
TXG
10x Genomics
-$0.29-$0.10+$0.19-$0.10$146.41 million$150.84 million
5/7/2026Q1 2026
Vontier Corporation stock logo
VNT
Vontier
$0.82$0.80-$0.02$0.66$737.21 million$750.60 million
5/6/2026Q1 2026
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
-$0.79-$0.99-$0.20-$0.99$0.35 million$0.70 million
4/28/2026Q1 2026
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
$0.09$0.10+$0.01-$0.01$244.78 million$257.60 million
CompanyAnnual PayoutDividend Yield5-Year Annualized Dividend GrowthPayout RatioYears of Consecutive Growth
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/AN/AN/AN/AN/A
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
N/AN/AN/AN/AN/A
10x Genomics stock logo
TXG
10x Genomics
N/AN/AN/AN/AN/A
Vontier Corporation stock logo
VNT
Vontier
$0.100.36%N/A3.53%N/A

Latest EYPT, MIR, VNT, and TXG Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/19/2026
Vontier Corporation stock logo
VNT
Vontier
quarterly$0.02500.35%6/4/20266/4/20266/25/2026
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
N/A
6.66
6.63
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
0.63
3.19
2.63
10x Genomics stock logo
TXG
10x Genomics
N/A
5.90
5.42
Vontier Corporation stock logo
VNT
Vontier
1.26
1.23
0.90

Institutional Ownership

CompanyInstitutional Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
99.41%
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
78.51%
10x Genomics stock logo
TXG
10x Genomics
84.68%
Vontier Corporation stock logo
VNT
Vontier
95.83%

Insider Ownership

CompanyInsider Ownership
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
5.13%
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
6.30%
10x Genomics stock logo
TXG
10x Genomics
8.84%
Vontier Corporation stock logo
VNT
Vontier
1.10%
CompanyEmployeesShares OutstandingFree FloatOptionable
Eyepoint Pharmaceuticals, Inc. stock logo
EYPT
Eyepoint Pharmaceuticals
12083.84 million79.54 millionOptionable
Mirion Technologies, Inc. stock logo
MIR
Mirion Technologies
3,281250.42 million234.64 millionOptionable
10x Genomics stock logo
TXG
10x Genomics
1,240126.96 million115.73 millionOptionable
Vontier Corporation stock logo
VNT
Vontier
7,800140.80 million139.25 millionOptionable

Recent News About These Companies

Vontier Corp
Vontier Corporation VNT Stock Forecast & Price Target

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Eyepoint Pharmaceuticals stock logo

Eyepoint Pharmaceuticals NASDAQ:EYPT

$11.78 -0.48 (-3.92%)
Closing price 04:00 PM Eastern
Extended Trading
$11.96 +0.19 (+1.57%)
As of 07:04 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

EyePoint Pharmaceuticals, Inc., a clinical-stage biopharmaceutical company, engages in developing and commercializing therapeutics to improve the lives of patients with serious retinal diseases. The company's pipeline leverages its proprietary bioerodible Durasert E technology for sustained intraocular drug delivery. Its lead product candidate is EYP-1901, an investigational sustained delivery treatment for VEGF-mediated retinal diseases combining vorolanib, a selective and patent-protected tyrosine kinase inhibitor with Durasert E which is in Phase 2 clinical trials for wet age-related macular degeneration (wet AMD), non-proliferative diabetic retinopathy (NPDR), and diabetic macular edema (DME). The company's pipeline programs also include EYP-2301, a promising TIE-2 agonist formulated in Durasert E to potentially improve outcomes in serious retinal diseases. The company was formerly known as pSivida Corp. and changed its name to EyePoint Pharmaceuticals, Inc. in March 2018. EyePoint Pharmaceuticals, Inc. was incorporated in 1987 and is headquartered in Watertown, Massachusetts.

Mirion Technologies stock logo

Mirion Technologies NYSE:MIR

$17.05 -1.17 (-6.40%)
Closing price 03:59 PM Eastern
Extended Trading
$17.14 +0.09 (+0.50%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Mirion Technologies, Inc. provides radiation detection, measurement, analysis, and monitoring products and services in the United States, Canada, the United Kingdom, France, Germany, Finland, China, Belgium, Netherlands, Estonia, South Korea, and Japan. It operates through two segments, Medical and Technologies. The Medical segment offers radiation oncology quality assurance and dosimetry solutions; patient safety solutions for diagnostic imaging and radiation therapy centers; radiation therapy quality assurance solutions for calibrating and verifying imaging and treatment accuracy; and radionuclide therapy products for nuclear medicine applications, such as shielding, product handling, medical imaging furniture, and rehabilitation products. This segment supports applications in medical diagnostics, cancer treatment, practitioner safety, and rehabilitation. The Technologies segment focuses on addressing critical radiation safety, measurement, and analysis applications; and provides personal radiation detection, identification equipment, and analysis tools. The company's products and solutions also include nuclear medicines, dosimeters, contamination and clearance monitors, reactor instrumentation and control equipment and systems, medical and industrial imaging systems and related accessories, alpha spectroscopy instruments, alpha/beta counting instruments, and gamma spectroscopy detector systems; and electrical penetration, cancer diagnostics, software, and other services. It serves hospitals, clinics and urgent care facilities, dental and veterinary offices, radiation treatment facilities, OEMs for radiation therapy, laboratories, military organizations, government agencies, industrial companies, power and utility companies, reactor design firms, and NPPs. The company was formerly known as Global Monitoring Systems, Inc. and changed its name to Mirion Technologies, Inc. in January 2006. The company was incorporated in 2005 and is headquartered in Atlanta, Georgia.

10x Genomics stock logo

10x Genomics NASDAQ:TXG

$31.04 -2.46 (-7.34%)
Closing price 04:00 PM Eastern
Extended Trading
$31.06 +0.02 (+0.05%)
As of 07:55 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in the America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium, chromium connect, and chromium controller instruments, microfluidic chips, slides, reagents, and other consumables products. Its single cell solutions runs on its chromium instruments, which include single cell gene expression for measuring gene activity and networks on a cell-by-cell basis; single cell gene expression flex; single cell immune profiling used to study the immune system; single cell Assay for Transposase Accessible Chromati (ATAC) solution to understand the epigenetic state; and single cell multiome ATAC + gene expression which enables simultaneous interrogation of both the RNA and chromatin accessibility, using ATAC in a single cell. The company also provides Visium platform which enables researchers to understand the spatial positions of biological analytes within tissues at high resolution; and Xenium platform for in situ analysis. It serves various academic, government, biopharmaceutical, biotechnology, and other institutions. The company was formerly known as 10X Technologies, Inc. and changed its name to 10x Genomics, Inc. in November 2014. 10x Genomics, Inc. was incorporated in 2012 and is headquartered in Pleasanton, California.

Vontier stock logo

Vontier NYSE:VNT

$28.19 -0.13 (-0.47%)
Closing price 03:59 PM Eastern
Extended Trading
$28.18 0.00 (-0.01%)
As of 07:57 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.

Vontier Corporation provides mobility ecosystem solutions worldwide. The company operates through Mobility Technologies, Repair Solutions, and Environmental and Fueling Solutions segments. The Mobility Technologies segment provides digitally equipment solutions for mobility ecosystem, such as point-of-sale and payment systems, workflow automation, telematics, data analytics, software platform, and integrated solutions for alternative fuel dispensing. The Repair Solutions segment manufactures and distributes vehicle repair tools, toolboxes, automotive diagnostic equipment and software through mobile franchise network. The Environmental and Fueling Solutions segment offers environmental, fueling hardware, software, and aftermarket solutions for fueling infrastructures. It also offers a range of solutions, including environmental sensors; fueling equipment; field payment hardware; point-of sale, workflow, and monitoring software; vehicle tracking and fleet management; software solutions for EV charging; and vehicle mechanics, and technicians equipment. The company markets its products and services to retail and commercial fueling, convenience store, and car wash operators; commercial vehicle repair businesses, fleet owners/operators and electric vehicle charging network operators, as well as direct sales personnel and independent distributors. It serves customers in North America, the Asia Pacific, Europe, and Latin America. Vontier Corporation was incorporated in 2019 and is headquartered in Raleigh, North Carolina.